PALSUCIBEP PEGOL
UNII ME55QQ2R4N

Substance Identification & Data

This profile provides standardized clinical and technical data for Palsucibep Pegol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ME55QQ2R4N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2218524-43-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ME55QQ2R4N
CAS Registry Number
2218524-43-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PALSUCIBEP PEGOL
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12075
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Palsucibep Pegol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PALSUCIBEP PEGOL

Common Names & Synonyms

PALSUCIBEP PEGOL [INN]
POLY(OXY-1,2-ETHANEDIYL), .ALPHA.-METHYL-.OMEGA.-HYDROXY-, 88-ETHER WITH LIPOCALIN 2 (RECOMBINANT HUMAN MUTEIN PRS-080) (88-(S-(1-(3-((3-HYDROXYPROPYL)AMINO)-3-OXOPROPYL)-2,5-DIOXO-3-PYRROLIDINYL)CYSTEINE))